Neuronetics Q2 revenue up 9.1% to $41.6M; EBITDA turns positive at $0.3M

Neuronetics, Inc.

Q2 total revenue $41.6M, +9.1% YoY; Greenbrook $26.9M +16.8%, NeuroStar $14.7M -2.7%.
Net loss narrowed to $3.4M ($0.05/sh) from $10.1M; adjusted EBITDA $0.3M vs -$5.6M.
Gross margin up to 51.1% from 46.6%; operating expenses down 12% to $22.7M.
FY2026 guidance: revenue narrowed to $160-164M; gross margin raised to 48-50%; opex cut to $95-100M.
Nir Naor named EVP/CFO; Cory Anderson promoted EVP/GM Greenbrook; Rob Greene SVP Sales.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.